Jazz DUET Study

The DUET Study will evaluate daytime and nighttime effects of XYWAV® (low-sodium oxybate oral solution), also known as JZP258, in people with idiopathic hypersomnia (IH) or narcolepsy (Type 1 or Type 2).

Interested in Participating?

To learn more about the DUET Study contact:
Clinical Trial Disclosure and Transparency

Additional study information is available at www.clinicaltrials.gov using the identifier NCT05875974

The full brochure can be found here